Access Official Technical PDF

Share Summary:LinkedInEmail

Natus Medical diagnostic systems cover a broad range of clinical tasks, from recording brain activity to screening newborn hearing and assessing balance disorders. The company’s 2021 annual report describes a portfolio built around devices, software, accessories, supplies, and technical services. For industrial automation professionals, the business offers a useful view of how specialized medical equipment combines signal acquisition, data handling, product quality, and customer support across varied care environments.

Natus Medical diagnostic systems span three clinical markets

Natus organized its products around three end markets: Neuro, Newborn Care, and Hearing & Balance. In 2021, Neuro represented approximately 60% of revenue, Newborn Care 22%, and Hearing & Balance 18%. These categories serve different clinical workflows, but each depends on acquiring or presenting information that helps healthcare professionals evaluate a patient.

The Neuro portfolio addresses neurodiagnostics, neurocritical care, and neurosurgery. It includes equipment for electroencephalography (EEG), electromyography (EMG), nerve conduction studies, evoked potentials, polysomnography (PSG), and intraoperative monitoring. Other products support intracranial pressure monitoring, cerebrospinal fluid drainage, and treatment of hydrocephalus.

Newborn Care products include hearing screeners, brain monitors, jaundice phototherapy equipment, retinal imaging systems, and supplies for neonatal intensive care units and well-baby nurseries. The Hearing & Balance portfolio serves hearing care professionals with assessment and hearing-aid fitting equipment, as well as vestibular diagnostic systems used to evaluate balance disorders.

From physiological signal to clinical review

Many Neuro systems follow a common technical pattern: sensors or electrodes collect physiological signals, amplifiers acquire them, and software records, displays, or analyzes the resulting data. In EEG, electrodes placed on the scalp detect electrical activity generated by the brain. Systems can capture EEG alongside synchronized video or other physiological signals, supporting routine assessments, long-term monitoring, and review in hospital or outpatient settings.

Different applications impose different requirements on data collection and interpretation. Long-term monitoring can help clinicians evaluate complex seizure cases, while intensive care monitoring supports observation of patients with severe head trauma or other acute conditions. Intraoperative monitoring uses methods such as EEG, EMG, and evoked potentials to observe neural function during surgery and provide information to the clinical team.

PSG systems collect a broader set of measurements during sleep studies. Depending on the study, these can include brain activity, muscle movement, airflow, respiratory effort, oxygen levels, and heart activity. Digital recording and analysis software help users review the collected information and prepare reports. Some systems are intended for laboratory use, while others support testing in a patient’s home.

In neurocritical care, catheters can measure intracranial pressure and, in some configurations, temperature. External drainage systems manage cerebrospinal fluid. These applications illustrate how a device portfolio may combine monitoring hardware with procedure-related equipment and consumables, rather than relying on a standalone instrument alone.

Newborn screening and monitoring applications

Newborn hearing screening uses two established approaches described in the report: auditory brainstem response (ABR) and otoacoustic emissions (OAE). ABR screening presents an auditory stimulus and detects the brain’s electrical response using electrodes. OAE screening uses a probe in the ear canal to deliver sound and measure responses associated with sensory cells in the cochlea. Screening devices analyze these responses to produce a pass-or-refer result.

Other newborn applications include cerebral function monitoring with amplitude-integrated EEG, retinal imaging for conditions requiring early evaluation, and phototherapy for jaundice management. Natus also described a secured live-video service that allows authorized family members to view a baby in the neonatal intensive care unit. Together, these applications show the range of equipment, software, and accessories used in a single care environment.

Manufacturing, quality, and service considerations

The annual report says Natus procured a significant portion of its components from other manufacturers while performing final assembly, testing, and packaging for many devices. It also used contract manufacturers for some disposable supplies and medical devices, with regular quality assessments that included on-site audits. This model places quality oversight across both internal operations and external manufacturing relationships.

For teams responsible for medical device production, the description highlights several operational touchpoints:

  • Component sourcing: Purchased components feed into products that may combine electronics, sensors, software, and patient-contact accessories.
  • Final assembly and testing: In-house work on many devices provides a defined stage for assembly, testing, and packaging before products are supplied to customers.
  • Supplier oversight: Contract manufacturing expands production capacity but also requires recurring quality assessment.
  • Service support: The company described repair, service, and calibration through company-owned facilities, field specialists, and, internationally, contracted vendors.

The report also distinguishes device and system sales from supplies and services. In 2021, devices and systems accounted for 75% of revenue, supplies 22%, and services 3%. This mix reflects a business that serves customers not only through equipment installations but also through recurring consumables and support activities.

Distribution and customer environments

Natus sold products through direct sales and distributors, with channel arrangements varying by geography and product. The report describes direct sales in North America and selected international markets, alongside distributors serving other regions. Distributors typically handled marketing, sales, and technical support in their territories, with the company providing training in product and service techniques.

Products were used in hospitals, clinics, physician offices, research laboratories, and patients’ homes. That range means equipment may need to support different operating environments, from a hospital monitoring room to ambulatory testing. The company also noted that hospital purchasing can be affected by calendar-year budgets, making order patterns seasonal.

Practical implications

Natus Medical’s 2021 portfolio demonstrates how diagnostic equipment integrates signal acquisition, analysis software, clinical accessories, manufacturing controls, and post-sale support. For automation and manufacturing leaders, the central operational consideration is coordination across the product lifecycle: sourced components and contract production must connect with assembly, testing, quality oversight, distribution, calibration, and service. In medical technology, these functions support systems intended for varied clinical workflows, where dependable data collection and appropriate technical support are integral parts of the offering.

Access Official Technical PDF

About The Author